4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-040108
EVP and General Counsel sold 1,329 shares at $100.00 ($132,900)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parschauer Karah Herdman EVP and General Counsel | 2021-06-10 | Sale | −1,329 | $100.00 | $132,900 | 28,668 | D: show line 1 in the form |
| Open-market sales · 1,329 sh · avg $100.00 · $132,900 | |||||||
Loading xslF345X03/doc4.xml…